Menu
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Takeda Pharmaceutical Company Limited American Depositary Shares (each (NY:TAK)

18.26 +0.15 (+0.83%)
Official Closing Price Updated: 7:00 PM EDT, Sep 11, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Takeda Pharmaceutical Company Limited American Depositary Shares (each

< Previous 1 2
...
14 15 16 17 18 19 20 21 Next >
News headline image
Takeda Data at ISTH 2021 Highlight the Benefits of Prophylaxis for Patients with Rare Bleeding Disorders
From Takeda Pharmaceutical Company Limited
Via Business Wire
News headline image
Moderna Extends Rally With Expanded Japanese COVID-19 Vaccine Supply Deal ↗
Moderna, Inc. (NASDAQ: MRNA) shares appear to be going from strength to strength, and the premarket price action Tuesday suggests a positive open for the fifth straight... 
Via Benzinga
News headline image
Japan To Buy Additional 50M Doses Of Moderna COVID-19 Vaccine ↗
Moderna Inc (NASDAQ: MRNA) has announced that the Ministry of Health, Labour and Welfare of Japan (MHLW) and Takeda Pharmaceutical Co Ltd (NYSE: TAK) will... 
Via Benzinga
News headline image
Takeda Announces the Submission of Its Corporate Governance Report to the Tokyo Stock Exchange
From Takeda Pharmaceutical Company Limited
Via Business Wire
News headline image
Timeless Values, Life-Changing Progress
SOURCE: Takeda 
Via 3BL Media
News headline image
Our Planet Commitment
SOURCE: Takeda 
Via 3BL Media
News headline image
Selloff Round 3 ↗
Stocks fell across the board in foreign countries, except for Britain which was upbeat. 
Via Talk Markets
News headline image
New Data from the Phase 3 HELP Study™ Open-Label Extension Evaluating Safety and Efficacy of TAKHZYRO® (lanadelumab) for Hereditary Angioedema Patients to be Presented at European Academy of Allergy and Clinical Immunology (EAACI) Hybrid Congress
From Takeda Pharmaceutical Company Limited
Via Business Wire
News headline image
Recovery Friday ↗
The big winners this week were Financials. 
Via Talk Markets
News headline image
Sell Sell Sell ↗
Today the inevitable reversal of wild gains overtook Wall Street, echoing what occurred in major foreign markets Monday. 
Via Talk Markets
News headline image
Attention Biotech Investors: Mark Your Calendar For July PDUFA Dates ↗
June was a month of plenty and also turned out to be a fruitful one from the perspective of Food and Drug Administration approvals. Regulatory reviews mostly produced positive... 
Via Benzinga
News headline image
End Of June ↗
Canadian Solar fell 4.6% on fears of plans for a China IPO where its panels are made. 
Via Talk Markets
Topics Initial Public Offering
News headline image
Takeda Announces the Publication of Its Annual Report on Form 20-F for FY2020
From Takeda Pharmaceutical Company Limited
Via Business Wire
News headline image
The Week Ahead In Biotech: Mediwound, Provention FDA Decisions, IPOs, Pending Clinical Readouts In Focus ↗
Biotech stocks reversed course and closed the week ended June 25 higher, thanks to the positive broader market sentiment. Eli Lilly and Company (NYSE: LLY) stood out among big... 
Via Benzinga
News headline image
Summer Friday ↗
The stock market tried for another record after yesterday's late blowout over the infrastructure deal. 
Via Talk Markets
News headline image
Crazy Thursday ↗
Today the US stock market went ballistic probably because of a higher joblessness level than expected. 
Via Talk Markets
News headline image
Wednesday Is A Normal Day ↗
Meme stocks Gamestop and Torchlight Energy both did share sales to cash in on their share price rises. 
Via Talk Markets
News headline image
The First Day Of Summer And Prime Day ↗
The bull is back in business today. 
Via Talk Markets
News headline image
The Week Ahead In Biotech: Incyte, Ascendis FDA Decisions, Liver Congress Presentations And 4 IPOs ↗
Biotech stocks came under pressure in the week ended June 18, dragged by the negative sentiment that prevailed in the broader market due to macroeconomic worries. The U.S. Federal... 
Via Benzinga
News headline image
Cathie Wood Sells Another $6.8M In 3D Printing Marketplace Shapeways' SPAC ↗
Cathie Wood-led Ark Investment Management on Thursday sold 679,335 shares, estimated to be worth about $6.8 million, in blank-check firm Ga... 
Via Benzinga
News headline image
Blueprint for Access to Innovative Healthcare Episode 2: Screening
SOURCE: Takeda 
Via 3BL Media
News headline image
Cathie Wood Adds $11M In Roblox On The Dip ↗
Cathie Wood-led Ark Investment Management on Wednesday snapped up 134,250 shares, estimated to be worth about $11.09 million, in Roblox Corp (NYSE: RBLX) on the dip. Shares of the... 
Via Benzinga
News headline image
Two Rate Hikes In 2023 ↗
This afternoon our Fed chief Jerome Powell predicted there will be interest rate hikes faster than before. The news hit US stocks, gold, and bitcoin hard. 
Via Talk Markets
Topics Economy
News headline image
Cathie Wood Loads Up $42M In DraftKings As Shares Drop On Short-Seller Report ↗
Cathie Wood-led Ark Investment Management on Tuesday snapped up 870,299 shares, estimated to be worth about $42.2 million, in DraftKings Inc (NASDAQ: DKNG) on the day shares of... 
Via Benzinga
News headline image
Continued Uncertainty ↗
Fear of another Fukushima yesterday late in the market day led to a rush out of energy-related shares, which included many without any nuclear risk at all. 
Via Talk Markets
News headline image
The Daily Biotech Pulse: AstraZeneca, Biogen Face Clinical Trial Disappointments, Novavax Studies Coronavirus-Flu Combo Vaccine, Decision Day For Takeda ↗
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs June 14) Alkermes plc (NASDAQ: ALKS... 
Via Benzinga
News headline image
Dreary Day ↗
Another dreary day and a renewed boost for cryptocurrency - and away from the classic inflation hedge, gold. 
Via Talk Markets
News headline image
The Week Ahead In Biotech: Takeda, Blueprint Medicines, Orphazyme, Eton On The Radar Ahead Of FDA Decisions, IPOs ↗
Biotech stocks extended their gains in the week ended June 11, supported by the broader market strength and some stock-specific moves. The biggest biotech news of the week came in the form of approval... 
Via Talk Markets
News headline image
The Week Ahead In Biotech: Takeda, Blueprint Medicines, Orphazyme, Eton On The Radar Ahead Of FDA Decisions, IPOs ↗
Biotech stocks extended their gains in the week ended June 11, supported by the broader market strength and some stock-specific moves. The biggest biotech news of the week came in... 
Via Benzinga
News headline image
Unheeding Markets ↗
Today oil prices rose over $70. 
Via Talk Markets
< Previous 1 2
...
14 15 16 17 18 19 20 21 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.